These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 41815)

  • 1. Hemodynamic characterization of bufuralol-HCl and pindolol based on the competitive effects of isoproterenol.
    Magometschnigg D; Bonelli J; Kaik G
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):429-32. PubMed ID: 41815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease of peripheral resistance after acute intravenous application of a new beta-receptor blocking agents, bufuralol HCl.
    Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G; Korn A
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):54-8. PubMed ID: 24595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic changes in hypertensive patients at rest and during physical exercise before and after acute i.v. administration of bufuralol-HCl or propranolol.
    Magometschnigg D; Bonelli J; Kaik G; Rameis H
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):334-40. PubMed ID: 39899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiohemodynamic effects of bopindolol in normotensive conscious dogs. A comparative study with pindolol.
    Ishibashi T; Mitomi A; Tatebe S; Imai S
    Arzneimittelforschung; 1989 Apr; 39(4):454-7. PubMed ID: 2568836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic effects of intravenous injection of beta-adrenergic inhibitor (Pindolol) in man].
    Scebat L; Rocha P; Ourbak P; Renais J; Lenègre J
    G Ital Cardiol; 1972; 2(5):626-35. PubMed ID: 4404052
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of a sodium lactate perfusion on the hemodynamic effects of beta-blockaders].
    Scebat A; Castan L; Renais R; Chiche J; Fernandez F; Gerbaux A
    Arch Mal Coeur Vaiss; 1978 Mar; 71(3):306-13. PubMed ID: 25055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocking potency of mepindolol and pindolol against isoproterenol-induced inotropic and chronotropic responses in guinea pig atria.
    Anderson WG
    J Cardiovasc Pharmacol; 1984; 6(1):7-11. PubMed ID: 6199615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative clinical and hemodynamic investigations on two beta-receptor blocking agents (pindolol and mepindolol) in normal subjects.
    Wink K
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):126-30. PubMed ID: 6715080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufuralol, a new beta-adrenoceptor blocking agent in a series of benzofuran-2-ethanolamines. Part 2: pharmacology.
    Hamilton TC; Parkes MW
    Arzneimittelforschung; 1977 Jul; 27(7):1410-7. PubMed ID: 20114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of two different types of beta1-receptors in man (selective blockade of the positively inotropic and the positively chronotropic effect of isoproterenol).
    Bonelli J
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):313-9. PubMed ID: 208993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An echocardiographic study of interactions between pindolol and epinephrine contained in a local anesthetic solution.
    Sugimura M; Hirota Y; Shibutani T; Niwa H; Hori T; Kim Y; Matsuura H
    Anesth Prog; 1995; 42(2):29-35. PubMed ID: 8934951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoproterenol blockade in man; comparison between penbutalol and acebutolol.
    Coleman AJ; Leary WP; Asmal AC
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):64-79. PubMed ID: 4149207
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-blocking and hemodynamic effects of ASL-8052.
    Gorczynski RJ; Murthy VS; Hwang TF
    J Cardiovasc Pharmacol; 1984; 6(6):1548-59. PubMed ID: 6084788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model for distinguishing between beta1-receptors which mediate a specific effect on the heart rate and those which mediate a positively inotropic effect.
    Bonelli J; Magometschnigg D; Hitzenberger G; Kaik G
    Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):381-3. PubMed ID: 19365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic long-term effects of a beta-receptor blockader (Pindolol) in primary essential hypertension].
    Klein WW; Brandt D; Fluch N; Goebel R; Holzer H; Pöch G
    Adv Clin Pharmacol; 1976; 11():79-85. PubMed ID: 1032573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.